Heat shock protein 72 expression allows permissive replication of oncolytic adenovirus dl1520 (ONYX-015) in rat glioblastoma cells

被引:10
|
作者
Madara, Jonathan
Krewet, James A.
Shah, Maulik [1 ]
机构
[1] St Louis Univ, Ctr Canc, St Louis, MO 63103 USA
[2] St Louis Univ, Sch Med, St Louis, MO 63103 USA
[3] St Louis Univ, Ctr Anat Studies, St Louis, MO 63103 USA
[4] St Louis Univ, Dept Pediat, Div Med Genet, St Louis, MO 63103 USA
关键词
D O I
10.1186/1476-4598-4-12
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In this study we have made novel observations with regards to potentiation of the tumoricidal activity of the oncolytic adenovirus, dII520 (ONYX-015) in rat glioblastoma cell lines expressing heat shock protein 72 (HSP72) due to permissive virus replication. ONYX-015 is a conditionally replicating adenovirus that is deleted for the EIB 55 kDA gene product whose normal function is to interact with cell-cycle regulatory proteins to permit virus replication. However, many murine and rodent cell lines are not permissive for adenovirus replication. Previously, it has been reported that the heat shock response is necessary for adenovirus replication and that induction of heat shock proteins is mediated by EI region gene products. Therefore, we hypothesized that HSP72 expression may allow for permissive replication of ONYX-015 in previously non-permissive cells. Rat glioma cell lines 9L and RT2 were transfected with a plasmids expressing HSP72 or GFP. After infection with ONYX-015, no tumoricidal activity is observed in GFP expressing cell lines despite adequate transduction. In contrast, HSP72 transfected cells show cytopathic effects by 72 hours and greater than 75% loss of viability by 96 hours. Burst assays show active virus replication in the HSP72 expressing cell lines. Therefore, 9L-HSP72 and RT2-HSP72 are ideal models to evaluate the efficacy of ONYX-015 in an immunocompetent rat model. Our study has implications for creating rodent tumor models for pre-clinical studies with EI region deleted conditionally replicating adenovirus.
引用
收藏
页数:10
相关论文
共 18 条
  • [1] Heat shock protein 72 expression allows permissive replication of oncolytic adenovirus dl1520 (ONYX-015) in rat glioblastoma cells
    Jonathan Madara
    James A Krewet
    Maulik Shah
    Molecular Cancer, 4
  • [2] Potentiation of radiation therapy by the oncolytic adenovirus dl1520 (ONYX-015) in human malignant glioma xenografts
    B Geoerger
    J Grill
    P Opolon
    J Morizet
    G Aubert
    Y Lecluse
    V W van Beusechem
    W R Gerritsen
    D H Kirn
    G Vassal
    British Journal of Cancer, 2003, 89 : 577 - 584
  • [3] Oncolytic virotherapy for cancer with the adenovirus dl1520 (Onyx-015):: results of Phase I and II trials
    Kirn, D
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2001, 1 (03) : 525 - 538
  • [4] Synergistic cytotoxicity against human tumor cell lines by oncolytic adenovirus dl1520 (ONYX-015) and melphalan
    Ferguson, Peter J.
    Sykelyk, Alexander
    Figueredo, Rene
    Koropatnick, James
    TUMORI, 2016, 102 (01) : 31 - 39
  • [5] Loss of p14ARF in tumor cells facilitates replication of the adenovirus mutant dl1520 (ONYX-015)
    Stefan J. Ries
    Christian H. Brandts
    Alicia S. Chung
    Carola H. Biederer
    Byron C. Hann
    Ettie M. Lipner
    Frank McCormick
    W. Michael Korn
    Nature Medicine, 2000, 6 : 1128 - 1133
  • [6] Loss of p14ARF in tumor cells facilitates replication of the adenovirus mutant dl1520 (ONYX-015)
    Ries, SJ
    Brandts, CH
    Chung, AS
    Biederer, CH
    Hann, BC
    Lipner, EM
    McCormick, F
    Korn, WM
    NATURE MEDICINE, 2000, 6 (10) : 1128 - 1133
  • [7] Does the antitumor adenovirus ONYX-015/dl1520 selectively target cells defective in the p53 pathway?
    Dix, BR
    Edwards, SJ
    Braithwaite, AW
    JOURNAL OF VIROLOGY, 2001, 75 (12) : 5443 - 5447
  • [8] Potentiation of radiation therapy by the oncolytic adenovirus dl 1520 (ONYX-015) in human malignant glioma xenografts
    Geoerger, B
    Grill, J
    Opolon, P
    Morizet, J
    Aubert, G
    Lecluse, Y
    van Beusechem, VW
    Gerritsen, WR
    Kirn, DH
    Vassal, G
    BRITISH JOURNAL OF CANCER, 2003, 89 (03) : 577 - 584
  • [9] Clinical research results with dl1520 (Onyx-015), a replication-selective adenovirus for the treatment of cancer: what have we learned?
    D Kirn
    Gene Therapy, 2001, 8 : 89 - 98
  • [10] Clinical research results with dl1520 (Onyx-015), a replication-selective adenovirus for the treatment of cancer: what have we learned?
    Kirn, D
    GENE THERAPY, 2001, 8 (02) : 89 - 98